Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study

Objectives To describe the prescribing trends of antihypertensive drugs in primary care patients and assess the trajectory of antihypertensive drug prescriptions, from first-line to third-line, in patients with hypertension according to changes to the United Kingdom (UK) hypertension management guid...

Full description

Saved in:
Bibliographic Details
Main Authors: Tibor Schuster, Laurent Azoulay, Julie Rouette, Emily G. McDonald, James M. Brophy
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/6/e057510.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584103441989632
author Tibor Schuster
Laurent Azoulay
Julie Rouette
Emily G. McDonald
James M. Brophy
author_facet Tibor Schuster
Laurent Azoulay
Julie Rouette
Emily G. McDonald
James M. Brophy
author_sort Tibor Schuster
collection DOAJ
description Objectives To describe the prescribing trends of antihypertensive drugs in primary care patients and assess the trajectory of antihypertensive drug prescriptions, from first-line to third-line, in patients with hypertension according to changes to the United Kingdom (UK) hypertension management guidelines.Design Population-based cohort study.Setting and participants We used the UK Clinical Practice Research Datalink, an electronic primary care database representative of the UK population. Between 1988 and 2018, we identified all adult patients with at least one prescription for a thiazide diuretic, angiotensin-converting enzyme (ACE) inhibitor, angiotensin receptor blocker, beta-blocker or calcium channel blocker (CCB).Primary and secondary outcome measures We estimated the period prevalence of patients with antihypertensive drug prescriptions for each calendar year over a 31-year period. Treatment trajectory was assessed by identifying patients with hypertension newly initiating an antihypertensive drug, and treatment changes were defined by a switch or add-on of a new class. This cohort was stratified before and after 2007, the year following important changes to UK hypertension management guidelines.Results The cohort included 2 709 241 patients. The prevalence of primary care patients with antihypertensive drug prescriptions increased from 7.8% (1988) to 21.9% (2018) and was observed for all major classes except thiazide diuretics. Patients with hypertension initiated thiazide diuretics (36.8%) and beta-blockers (23.6%) as first-line drugs before 2007, and ACE inhibitors (39.9%) and CCBs (31.8%) after 2007. After 2007, 17.3% were not prescribed guideline-recommended first-line agents. Overall, patients were prescribed a median of 2 classes (IQR 1–2) after first-line treatment.Conclusion Nearly one-quarter of primary care patients were prescribed antihypertensive drugs by the end of the study period. Most patients with hypertension initiated guideline-recommended first-line agents. Not all patients, particularly females, were prescribed recommended agents however, potentially leading to suboptimal cardiovascular outcomes. Future research should aim to better understand the implication of this finding.
format Article
id doaj-art-e44b02d5eede4c53b63a1c65b3eaa827
institution Kabale University
issn 2044-6055
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-e44b02d5eede4c53b63a1c65b3eaa8272025-01-27T19:10:13ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2021-057510Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort studyTibor Schuster0Laurent Azoulay1Julie Rouette2Emily G. McDonald3James M. Brophy4Clinical Epidemiology and Biostatistics Unit, McGill University, Montreal, Quebec, CanadaDepartment of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Québec, Canada2 Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, CanadaMedicine, McGill University, Montreal, Quebec, Canada1 Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, CanadaObjectives To describe the prescribing trends of antihypertensive drugs in primary care patients and assess the trajectory of antihypertensive drug prescriptions, from first-line to third-line, in patients with hypertension according to changes to the United Kingdom (UK) hypertension management guidelines.Design Population-based cohort study.Setting and participants We used the UK Clinical Practice Research Datalink, an electronic primary care database representative of the UK population. Between 1988 and 2018, we identified all adult patients with at least one prescription for a thiazide diuretic, angiotensin-converting enzyme (ACE) inhibitor, angiotensin receptor blocker, beta-blocker or calcium channel blocker (CCB).Primary and secondary outcome measures We estimated the period prevalence of patients with antihypertensive drug prescriptions for each calendar year over a 31-year period. Treatment trajectory was assessed by identifying patients with hypertension newly initiating an antihypertensive drug, and treatment changes were defined by a switch or add-on of a new class. This cohort was stratified before and after 2007, the year following important changes to UK hypertension management guidelines.Results The cohort included 2 709 241 patients. The prevalence of primary care patients with antihypertensive drug prescriptions increased from 7.8% (1988) to 21.9% (2018) and was observed for all major classes except thiazide diuretics. Patients with hypertension initiated thiazide diuretics (36.8%) and beta-blockers (23.6%) as first-line drugs before 2007, and ACE inhibitors (39.9%) and CCBs (31.8%) after 2007. After 2007, 17.3% were not prescribed guideline-recommended first-line agents. Overall, patients were prescribed a median of 2 classes (IQR 1–2) after first-line treatment.Conclusion Nearly one-quarter of primary care patients were prescribed antihypertensive drugs by the end of the study period. Most patients with hypertension initiated guideline-recommended first-line agents. Not all patients, particularly females, were prescribed recommended agents however, potentially leading to suboptimal cardiovascular outcomes. Future research should aim to better understand the implication of this finding.https://bmjopen.bmj.com/content/12/6/e057510.full
spellingShingle Tibor Schuster
Laurent Azoulay
Julie Rouette
Emily G. McDonald
James M. Brophy
Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study
BMJ Open
title Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study
title_full Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study
title_fullStr Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study
title_full_unstemmed Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study
title_short Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study
title_sort treatment and prescribing trends of antihypertensive drugs in 2 7 million uk primary care patients over 31 years a population based cohort study
url https://bmjopen.bmj.com/content/12/6/e057510.full
work_keys_str_mv AT tiborschuster treatmentandprescribingtrendsofantihypertensivedrugsin27millionukprimarycarepatientsover31yearsapopulationbasedcohortstudy
AT laurentazoulay treatmentandprescribingtrendsofantihypertensivedrugsin27millionukprimarycarepatientsover31yearsapopulationbasedcohortstudy
AT julierouette treatmentandprescribingtrendsofantihypertensivedrugsin27millionukprimarycarepatientsover31yearsapopulationbasedcohortstudy
AT emilygmcdonald treatmentandprescribingtrendsofantihypertensivedrugsin27millionukprimarycarepatientsover31yearsapopulationbasedcohortstudy
AT jamesmbrophy treatmentandprescribingtrendsofantihypertensivedrugsin27millionukprimarycarepatientsover31yearsapopulationbasedcohortstudy